therascreen PIK3CA PLASMA RGQ PCR Kit

Somatic Gene Mutation Detection System

FDA Premarket Approval P190004

Pre-market Approval Supplement Details

The therascreen pik3ca rgq pcr kit is a real-time qualitative pcr test for the detection of 11 mutations in the phosphatidylinositol 3-kinase catalytic subunit alpha (pik3ca) gene (exon 7: c420r; exon 9: e542k, e545a, e545d [1635g>t only], e545g, e545k, q546e, q546r; and exon 20: h1047l, h1047r, h1047y) using genomic dna (gdna) extracted from formalin-fixed, paraffin-embedded (ffpe) breast tumor tissue or circulating tumor dna (ctdna) from plasma derived from k2edta anticoagulated peripheral whole blood taken from patients with breast cancer. The test is intended to aid clinicians in identifying breast cancer patients who may be eligible for treatment with piqray® (alpelisib) based on a pik3ca mutation detected result. Patients whose ffpe tissue or plasma specimen produce a positive therascreen pik3ca rgq pcr kit test result for the presence of one or more pik3ca mutations are eligible for treatment with piqray (alpelisib). Patients whose plasma specimens produces a negative result using this test should be reflexed to testing with ffpe tumor tissue for the presence of pik3ca mutations. Ffpe tumor specimens are processed using the qiaamp dsp dna ffpe tissue kit for manual sample preparation. K2edta anticoagulated whole peripheral venous blood plasma specimens are processed using the qiaamp dsp circulating nucleic acid kit for manual sample preparation. For both specimen types, the rotor-gene q (rgq) mdx (us) instrument is used for automated amplification and detection. The kit is to be used by trained personnel in a professional laboratory environment.

Devicetherascreen PIK3CA PLASMA RGQ PCR Kit
Classification NameSomatic Gene Mutation Detection System
Generic NameSomatic Gene Mutation Detection System
ApplicantQIAGEN GmbH
Date Received2019-02-15
Decision Date2019-05-24
PMAP190004
SupplementS
Product CodeOWD
Advisory CommitteeMolecular Genetics
Expedited ReviewNo
Combination Product No
Applicant Address QIAGEN GmbH qiagen Strasse 1 hilden 40724

Supplemental Filings

A PHP Error was encountered

Severity: Notice

Message: Undefined offset: 0

Filename: fda.report/pma_item.php

Line Number: 133

Backtrace:

File: /var/www/fda.report/pma_item.php
Line: 133
Function: _error_handler

Supplement NumberDateSupplement Type
P190004Original Filing

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.